World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
18528
World Ranking
2060
National Ranking
180

Overview

Ray Borrow is affiliated with Manchester Royal Infirmary in the United Kingdom. Their research primarily focuses on Medicine and Immunology and Microbiology, with a substantial number of publications in these fields.

The scientist's work covers several subfields, including:

  • Epidemiology
  • Microbiology
  • Infectious Diseases
  • Immunology
  • Health

Major topics covered in their research include:

  • Bacterial Infections and Vaccines
  • Pneumonia and Respiratory Infections
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Virology and Viral Diseases
  • Respiratory viral infections research

Ray Borrow has frequently published in several venues, with notable numbers in these journals and platforms:

  • Journal of Infection
  • Vaccine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Human Vaccines & Immunotherapeutics
  • Expert Review of Vaccines

Frequent co-authors collaborating with Ray Borrow include:

  • Shamez Ladhani
  • Mary Ramsay
  • Ezra Linley
  • Jay Lucidarme
  • Gayatri Amirthalingam

Some recent papers authored by Ray Borrow and colleagues are:

  • Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data, 2021, The Lancet Digital Health
  • Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection, 2021, Nature Immunology
  • Vaccines and routine immunization strategies during the COVID-19 pandemic, 2020, Human Vaccines & Immunotherapeutics
  • The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination, 2020, Journal of Infection
  • Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection, 2021, Nature Immunology

Best Publications

  • Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

    Shamez N Ladhani;Shamez N Ladhani;Sarah Collins;Abdelmajid Djennad;Carmen L Sheppard

  • Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data.

    Angela B. Brueggemann;Melissa J. Jansen van Rensburg;David Shaw;Noel D. McCarthy

  • Meningococcal surrogates of protection--serum bactericidal antibody activity.

    Raymond Borrow;Paul Balmer;Elizbeth Miller

  • Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.

    Jianmin Zuo;Alexander C Dowell;Hayden Pearce;Kriti Verma

  • Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

    Jamie Findlow;Ray Borrow;Matthew D. Snape;Tom Dawson

  • Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment

    Ulrich Vogel;Muhamed-Kheir Taha;Julio A Vazquez;Jamie Findlow

  • Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

    Sydel R Parikh;Nick J Andrews;Kazim Beebeejaun;Helen Campbell

  • Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

    Robert C Read;David Baxter;David R Chadwick;Saul N Faust;Saul N Faust

  • Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity

    Helen Campbell;Nick Andrews;Ray Borrow;Caroline Trotter

  • Advances in the development of vaccines against Neisseria meningitidis.

    Lionel K K Tan;George M Carlone;Ray Borrow

  • Vaccines and routine immunization strategies during the COVID-19 pandemic.

    Ener Cagri Dinleyici;Ray Borrow;Marco Aurélio Palazzi Safadi;Pierre van Damme

  • The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

    Ray Borrow;Pedro Alarcón;Josefina Carlos;Dominique A. Caugant

  • Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease.

    Carl E. Frasch;Ray Borrow;John Donnelly

  • Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.

    R. Borrow;G.M. Carlone;N. Rosenstein;M. Blake

  • Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage

    Jay Lucidarme;Dorothea M.C. Hill;Holly B. Bratcher;Steve J. Gray

  • The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults

    F McGill;R S Heyderman;B D Michael;B D Michael;S Defres;S Defres;S Defres

  • Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup B Neisseria meningitidis

    Ellen Murphy;Lubomira Andrew;Kwok Leung Lee;Deborah A. Dilts

  • Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales

    Shamez Ladhani;Kazim Beebeejaun;Jay Lucidarme;Helen Campbell

  • Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit.

    Stephen J. Gray;Caroline L. Trotter;Mary E. Ramsay;Malcolm Guiver

  • Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

    Keith Cartwright;Rhonwen Morris;Hans Rümke;Andrew Fox

  • The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination.

    Sydel R. Parikh;Helen Campbell;Julie A. Bettinger;Lee H. Harrison

  • Meningococcal C conjugate vaccine: the experience in England and Wales.

    Helen Campbell;Ray Borrow;David Salisbury;Elizabeth Miller

Frequent Co-Authors

Shamez N. Ladhani
Shamez N. Ladhani UK Health Security Agency
Mary Ramsay
Mary Ramsay UK Health Security Agency
Elizabeth Miller
Elizabeth Miller London School of Hygiene & Tropical Medicine
Nick Andrews
Nick Andrews Salk Institute for Biological Studies
Andrew J. Fox
Andrew J. Fox Manchester Royal Infirmary
Elizabeth Miller
Elizabeth Miller Stanford University
David Goldblatt
David Goldblatt University College London
Robert C. Read
Robert C. Read University of Southampton
Paul T. Heath
Paul T. Heath St George's, University of London
Muhamed-Kheir Taha
Muhamed-Kheir Taha Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Many choose to pursue nursing pathways, including Licensed Practical Nurse (LPN) programs known for easier admission standards. Those looking for accessible options might consider lpn programs with easiest admission requirements that can serve as stepping stones into clinical roles supporting immunological research and patient care.

Further advancement can be achieved through Nurse Practitioner programs. Online platforms currently offer some of the easiest online nurse practitioner programs, making it more feasible for working professionals to upgrade their qualifications while balancing other responsibilities.

For those with a focus on mental health within immunology, there are excellent options such as top psychiatric mental health nurse practitioner programs online. These programs often provide strong clinical placements critical for hands-on experience and career growth.

Cost is also a major consideration, and students can find affordable routes through cheap psych np programs that maintain quality education standards without excessive financial burdens. Exploring these connected pathways can help students align their career goals with practical opportunities in the healthcare and immunology fields.

Best Scientists Citing Ray Borrow

Trending Scientists

Recently Published Articles